AboutBlogOver 40,000+ FDA inspection documents: 483s, EIRs, 483Rs

EIR Yiling Pharmaceutical, Nov 2019

NaN - Available for instant download
by

FDA investigators audited the Yiling Pharmaceutical - Shijiazhuang, China facility and issued inspectional observations (via FDA 483) on 21 Nov 2019.

Product Details

  • Category: Human Drugs
  • Inspection end: 21 Nov 2019
  • Location: Shijiazhuang, China
  • FEI: 3011640199
Yiling Pharmaceutical FDA inspection 483 Nov 2019